Question 1

Which Wall Street gurus hold Protagonist Therapeutics Inc (PTGX)?

Accepted Answer

Per the latest SEC 13F filings, 16 Wall Street gurus hold PTGX. Top holders include 조셉 에델만, 스탠리 드러켄밀러, 켄 그리핀, with a combined position value of about $2.05B.

Question 2

What sector does Protagonist Therapeutics Inc belong to?

Accepted Answer

Protagonist Therapeutics Inc (PTGX) is in the Biotechnology sector / Biotechnology industry, listed on NASDAQ NMS - GLOBAL MARKET.

Question 3

What are the key financial metrics for Protagonist Therapeutics Inc?

Accepted Answer

Key metrics for Protagonist Therapeutics Inc (PTGX): EPS $-1.80, Beta 1.76. Live price and chart are at the top of the page.

Question 4

What is a 13F report?

Accepted Answer

A 13F is a quarterly filing institutional investors submit to the US Securities and Exchange Commission (SEC) disclosing their equity holdings. It is mandatory for managers with at least $100M in AUM and must be filed within 45 days of the quarter end.

#	Investor	Weight	Shares	Value	Activity
1	Joseph Edelman Perceptive Advisors LLC	2.55%	1,230,879	$129.73M	HOLD
2	Stanley Druckenmiller Duquesne Family Office LLC	0.50%	159,700	$16.83M	HOLD
3	Ken Griffin Citadel Advisors LLC	0.03%	1,551,900	$163.57M	HOLD
4	T. Rowe Price T. Rowe Price Associates	0.02%	1,665,497	$175.54M	HOLD
5	BlackRock BlackRock Inc	0.02%	9,779,369	$1.03B	HOLD
6	Dmitry Balyasny Balyasny Asset Management LP	0.01%	101,299	$10.68M	HOLD
7	State Street State Street Global Advisors	0.01%	3,116,749	$328.51M	HOLD
8	Goldman Sachs Goldman Sachs Asset Management	0.01%	778,945	$82.10M	HOLD
9	Joel Greenblatt Gotham Asset Management LLC	0.01%	21,155	$2.23M	HOLD
10	Ken Fisher Fisher Asset Management LLC	0.01%	173,971	$18.34M	HOLD
11	Ron Baron Baron Capital Group Inc	0.00%	15,000	$1.58M	HOLD
12	Fidelity (FMR) Fidelity Management & Research	0.00%	661,997	$69.77M	HOLD
13	Ray Dalio Bridgewater Associates LP	0.00%	5,276	$556,090	HOLD
14	Paul Tudor Jones Tudor Investment Corp	0.00%	6,200	$653,480	HOLD
15	JPMorgan Chase JPMorgan Asset Management	0.00%	172,990	$17.28M	HOLD
16	Cliff Asness AQR Capital Management LLC	0.00%	11,874	$1.25M	HOLD

Insider	Title	Type	Shares	Value	Date
PATEL DINESH V PH D	President and CEO	SELL	1,460	--	4/23/2026
Ali Asif	Chief Financial Officer	SELL	1,750	$0.2M	4/20/2026

Protagonist Therapeutics Inc

Holders (16)

Insider Trades (2)

Related Articles (1)